Results 101 to 110 of about 3,430,759 (315)

The invisible scissors: Media freedom and censorship in Switzerland

open access: yes, 2010
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.At first glance, the very idea of analysing the freedom of the media and of researching censorship in Switzerland seems absurd.
Höchli, Marc
core  

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher   +10 more
wiley   +1 more source

Efficient Electricity Portfolios for Switzerland and the United States [PDF]

open access: yes
This study applies financial portfolio theory to determine efficient electricity-generating technology mixes for Switzerland and the United States. Expected returns are given by the (negative of the) rate of increase of power generation cost.
Peter Zweifel, Boris Krey
core  

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem   +17 more
wiley   +1 more source

Saas [cartographic material] /

open access: yes, 1888
Revision. Topographic map of Sass Almagell region of Switzerland and Antronapiana region of Italy. Relief shown by contour lines, spot heights and landforms.; Zusa?tzliche Nummerierung: Section XXIII, 2.; Also available in an electronic version via the ...
Switzerland. Eidgeno?ssisches Stabsbureau.
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller   +14 more
wiley   +1 more source

“The colossal and the well-ordered” or about culture and management in Switzerland [PDF]

open access: yes
This paper tries to describe for students, for managers, for tourists, the complex experience that I had travelling, for the second time, in the summer of 2010, for a few weeks, in Switzerland, visiting friends, but also discovering again cities, towns ...
Amedeo ISTOCESCU
core  

CT-scans of pathological cranial fragments from Barmaz II, Neolithic Switzerland: a differential diagnosis

open access: yesUISPP Journal, 2019
Whilst undertaking a paleoepidemiological study of the neolithic and Bell Beaker culture populations of western Switzerland, a strange case was uncovered in the necropolis of Barmaz II.
Claudine Abegg   +3 more
doaj   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy